Loomis, Sayles & Company
THC icon

Loomis, Sayles & Company’s Tenet Healthcare THC Stock Holding History

Loomis, Sayles & Company’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.36M Buy
50,058
+49,981
+64,910% +$9.19M 0.01% 398
2026
Q1 		$14.5K Sell
77
-434
-85% -$91.4K ﹤0.01% 697
2025
Q4 		$101K Hold
511
– – ﹤0.01% 576
2025
Q3 		$104K Sell
511
-8,654
-94% -$1.54M ﹤0.01% 559
2025
Q2 		$1.61M Sell
9,165
-45,905
-83% -$6.91M ﹤0.01% 472
2025
Q1 		$7.41M Sell
55,070
-96,073
-64% -$12.7M 0.01% 391
2024
Q4 		$19.1M Sell
151,143
-119,157
-44% -$17.7M 0.02% 264
2024
Q3 		$44.9M Sell
270,300
-44,011
-14% -$6.66M 0.06% 144
2024
Q2 		$41.8M Sell
314,311
-63,546
-17% -$7.65M 0.06% 142
2024
Q1 		$39.7M Sell
377,857
-30,196
-7% -$2.71M 0.06% 161
2023
Q4 		$30.8M Sell
408,053
-39,092
-9% -$2.48M 0.05% 193
2023
Q3 		$29.5M Buy
447,145
+21,237
+5% +$1.59M 0.05% 189
2023
Q2 		$34.7M Buy
425,908
+21,533
+5% +$1.53M 0.06% 163
2023
Q1 		$24M Sell
404,375
-590
-0.1% -$32.8K 0.04% 212
2022
Q4 		$19.8M Buy
404,965
+58,097
+17% +$2.69M 0.04% 229
2022
Q3 		$17.9M Buy
+346,868
New +$20.6M 0.04% 224
2018
Q4 		– Sell
-264
Closed -$8K – 936
2018
Q3 		$8K Buy
+264
New +$8.72K ﹤0.01% 845

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Loomis, Sayles & Company's THC Position: Q2 2026 in Review

Loomis, Sayles & Company increased its Tenet Healthcare (THC) stake by 64,910% in Q2 2026, buying an estimated $9.19M and bringing the position to 50,058 shares worth $9.36M. The position accounts for 0.01% of the portfolio, ranked #398.

Loomis, Sayles & Company first reported a position in THC in Q3 2018 and has held it in 17 quarters since. The position peaked at $44.9M in Q3 2024. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Loomis, Sayles & Company held 50,058 shares of Tenet Healthcare worth $9.36M as of Q2 2026.
  • Loomis, Sayles & Company bought 49,981 Tenet Healthcare shares in Q2 2026, an estimated $9.19M.
  • Tenet Healthcare made up 0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #398 holding.
  • Loomis, Sayles & Company first reported a position in Tenet Healthcare in Q3 2018 and has held it in 17 quarters since.
  • Loomis, Sayles & Company's Tenet Healthcare position peaked at $44.9M in Q3 2024.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.